0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pediatric Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-13M6952
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pediatric Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Pediatric Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13M6952
Report
October 2024
Pages:158
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pediatric Vaccines - Market Size

The global market for Pediatric Vaccines was estimated to be worth US$ 29730 million in 2023 and is forecast to a readjusted size of US$ 45100 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

Pediatric Vaccines - Market

Pediatric Vaccines - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pediatric Vaccines by region & country, by Type, and by Application.
The Pediatric Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Vaccines.
Market Segmentation

Scope of Pediatric Vaccines - Market Report

Report Metric Details
Report Name Pediatric Vaccines - Market
Forecasted market size in 2030 US$ 45100 million
CAGR 5.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Diphtheria
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Meningococcal Diseases
  • Others
Segment by Application
  • Newborn
  • Infant
  • Child
  • Dolescent
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Pediatric Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pediatric Vaccines - Market size in 2030?

Ans: The Pediatric Vaccines - Market size in 2030 will be US$ 45100 million.

Who are the main players in the Pediatric Vaccines - Market report?

Ans: The main players in the Pediatric Vaccines - Market are GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India

What are the Application segmentation covered in the Pediatric Vaccines - Market report?

Ans: The Applications covered in the Pediatric Vaccines - Market report are Newborn, Infant, Child, Dolescent

What are the Type segmentation covered in the Pediatric Vaccines - Market report?

Ans: The Types covered in the Pediatric Vaccines - Market report are Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others

1 Market Overview
1.1 Pediatric Vaccines Product Introduction
1.2 Global Pediatric Vaccines Market Size Forecast
1.2.1 Global Pediatric Vaccines Sales Value (2019-2030)
1.2.2 Global Pediatric Vaccines Sales Volume (2019-2030)
1.2.3 Global Pediatric Vaccines Sales Price (2019-2030)
1.3 Pediatric Vaccines Market Trends & Drivers
1.3.1 Pediatric Vaccines Industry Trends
1.3.2 Pediatric Vaccines Market Drivers & Opportunity
1.3.3 Pediatric Vaccines Market Challenges
1.3.4 Pediatric Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pediatric Vaccines Players Revenue Ranking (2023)
2.2 Global Pediatric Vaccines Revenue by Company (2019-2024)
2.3 Global Pediatric Vaccines Players Sales Volume Ranking (2023)
2.4 Global Pediatric Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Pediatric Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Pediatric Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pediatric Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pediatric Vaccines
2.9 Pediatric Vaccines Market Competitive Analysis
2.9.1 Pediatric Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diphtheria
3.1.2 Influenza
3.1.3 Hepatitis
3.1.4 Pneumococcal Diseases
3.1.5 Meningococcal Diseases
3.1.6 Others
3.2 Global Pediatric Vaccines Sales Value by Type
3.2.1 Global Pediatric Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pediatric Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Pediatric Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Pediatric Vaccines Sales Volume by Type
3.3.1 Global Pediatric Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pediatric Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Pediatric Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Pediatric Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.1.4 Dolescent
4.2 Global Pediatric Vaccines Sales Value by Application
4.2.1 Global Pediatric Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pediatric Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Pediatric Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Pediatric Vaccines Sales Volume by Application
4.3.1 Global Pediatric Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pediatric Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Pediatric Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Pediatric Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pediatric Vaccines Sales Value by Region
5.1.1 Global Pediatric Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pediatric Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Pediatric Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Pediatric Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Pediatric Vaccines Sales Volume by Region
5.2.1 Global Pediatric Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pediatric Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Pediatric Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Pediatric Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Pediatric Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pediatric Vaccines Sales Value, 2019-2030
5.4.2 North America Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pediatric Vaccines Sales Value, 2019-2030
5.5.2 Europe Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pediatric Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pediatric Vaccines Sales Value, 2019-2030
5.7.2 South America Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pediatric Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pediatric Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pediatric Vaccines Sales Value
6.2.1 Key Countries/Regions Pediatric Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pediatric Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pediatric Vaccines Sales Value, 2019-2030
6.3.2 United States Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pediatric Vaccines Sales Value, 2019-2030
6.4.2 Europe Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pediatric Vaccines Sales Value, 2019-2030
6.5.2 China Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pediatric Vaccines Sales Value, 2019-2030
6.6.2 Japan Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pediatric Vaccines Sales Value, 2019-2030
6.7.2 South Korea Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pediatric Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pediatric Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pediatric Vaccines Sales Value, 2019-2030
6.9.2 India Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pediatric Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Information
7.1.2 GlaxoSmithKline Introduction and Business Overview
7.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GlaxoSmithKline Pediatric Vaccines Product Offerings
7.1.5 GlaxoSmithKline Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Pediatric Vaccines Product Offerings
7.2.5 Merck Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Pediatric Vaccines Product Offerings
7.3.5 Pfizer Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Pediatric Vaccines Product Offerings
7.4.5 Sanofi Recent Development
7.5 AstraZeneca
7.5.1 AstraZeneca Company Information
7.5.2 AstraZeneca Introduction and Business Overview
7.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AstraZeneca Pediatric Vaccines Product Offerings
7.5.5 AstraZeneca Recent Development
7.6 Novartis
7.6.1 Novartis Company Information
7.6.2 Novartis Introduction and Business Overview
7.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novartis Pediatric Vaccines Product Offerings
7.6.5 Novartis Recent Development
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Information
7.7.2 Takeda Pharmaceutical Introduction and Business Overview
7.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Takeda Pharmaceutical Pediatric Vaccines Product Offerings
7.7.5 Takeda Pharmaceutical Recent Development
7.8 Bavarian Nordic
7.8.1 Bavarian Nordic Company Information
7.8.2 Bavarian Nordic Introduction and Business Overview
7.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bavarian Nordic Pediatric Vaccines Product Offerings
7.8.5 Bavarian Nordic Recent Development
7.9 Baxter
7.9.1 Baxter Company Information
7.9.2 Baxter Introduction and Business Overview
7.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Baxter Pediatric Vaccines Product Offerings
7.9.5 Baxter Recent Development
7.10 LG Life Sciences
7.10.1 LG Life Sciences Company Information
7.10.2 LG Life Sciences Introduction and Business Overview
7.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 LG Life Sciences Pediatric Vaccines Product Offerings
7.10.5 LG Life Sciences Recent Development
7.11 Lupin
7.11.1 Lupin Company Information
7.11.2 Lupin Introduction and Business Overview
7.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Lupin Pediatric Vaccines Product Offerings
7.11.5 Lupin Recent Development
7.12 S K Chemicals
7.12.1 S K Chemicals Company Information
7.12.2 S K Chemicals Introduction and Business Overview
7.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 S K Chemicals Pediatric Vaccines Product Offerings
7.12.5 S K Chemicals Recent Development
7.13 Mitsubishi Tanabe Pharma
7.13.1 Mitsubishi Tanabe Pharma Company Information
7.13.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
7.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offerings
7.13.5 Mitsubishi Tanabe Pharma Recent Development
7.14 Janssen
7.14.1 Janssen Company Information
7.14.2 Janssen Introduction and Business Overview
7.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Janssen Pediatric Vaccines Product Offerings
7.14.5 Janssen Recent Development
7.15 Shenzhen Kangtai Biological Products
7.15.1 Shenzhen Kangtai Biological Products Company Information
7.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
7.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offerings
7.15.5 Shenzhen Kangtai Biological Products Recent Development
7.16 Sinovac Biotech
7.16.1 Sinovac Biotech Company Information
7.16.2 Sinovac Biotech Introduction and Business Overview
7.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Sinovac Biotech Pediatric Vaccines Product Offerings
7.16.5 Sinovac Biotech Recent Development
7.17 Bharat Biotech
7.17.1 Bharat Biotech Company Information
7.17.2 Bharat Biotech Introduction and Business Overview
7.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Bharat Biotech Pediatric Vaccines Product Offerings
7.17.5 Bharat Biotech Recent Development
7.18 Crucell
7.18.1 Crucell Company Information
7.18.2 Crucell Introduction and Business Overview
7.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Crucell Pediatric Vaccines Product Offerings
7.18.5 Crucell Recent Development
7.19 Dynavax
7.19.1 Dynavax Company Information
7.19.2 Dynavax Introduction and Business Overview
7.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Dynavax Pediatric Vaccines Product Offerings
7.19.5 Dynavax Recent Development
7.20 Serum Institute of India
7.20.1 Serum Institute of India Company Information
7.20.2 Serum Institute of India Introduction and Business Overview
7.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Serum Institute of India Pediatric Vaccines Product Offerings
7.20.5 Serum Institute of India Recent Development
8 Industry Chain Analysis
8.1 Pediatric Vaccines Industrial Chain
8.2 Pediatric Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pediatric Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Pediatric Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pediatric Vaccines Market Trends
    Table 2. Pediatric Vaccines Market Drivers & Opportunity
    Table 3. Pediatric Vaccines Market Challenges
    Table 4. Pediatric Vaccines Market Restraints
    Table 5. Global Pediatric Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pediatric Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Pediatric Vaccines Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Pediatric Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Pediatric Vaccines Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Pediatric Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Pediatric Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Pediatric Vaccines
    Table 13. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pediatric Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Pediatric Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Pediatric Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Pediatric Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Pediatric Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Pediatric Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Pediatric Vaccines Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Pediatric Vaccines Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Pediatric Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Pediatric Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Pediatric Vaccines Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Pediatric Vaccines Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Pediatric Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Pediatric Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Pediatric Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Pediatric Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Pediatric Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Pediatric Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Pediatric Vaccines Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Pediatric Vaccines Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Pediatric Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Pediatric Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Pediatric Vaccines Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Pediatric Vaccines Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Pediatric Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Pediatric Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Pediatric Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Pediatric Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Pediatric Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Pediatric Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Pediatric Vaccines Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Pediatric Vaccines Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Pediatric Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Pediatric Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Pediatric Vaccines Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Pediatric Vaccines Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Pediatric Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Pediatric Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Pediatric Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Pediatric Vaccines Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Pediatric Vaccines Sales Volume, (2025-2030) & (K Units)
    Table 57. GlaxoSmithKline Company Information
    Table 58. GlaxoSmithKline Introduction and Business Overview
    Table 59. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. GlaxoSmithKline Pediatric Vaccines Product Offerings
    Table 61. GlaxoSmithKline Recent Development
    Table 62. Merck Company Information
    Table 63. Merck Introduction and Business Overview
    Table 64. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Merck Pediatric Vaccines Product Offerings
    Table 66. Merck Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Pediatric Vaccines Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Sanofi Company Information
    Table 73. Sanofi Introduction and Business Overview
    Table 74. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Sanofi Pediatric Vaccines Product Offerings
    Table 76. Sanofi Recent Development
    Table 77. AstraZeneca Company Information
    Table 78. AstraZeneca Introduction and Business Overview
    Table 79. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. AstraZeneca Pediatric Vaccines Product Offerings
    Table 81. AstraZeneca Recent Development
    Table 82. Novartis Company Information
    Table 83. Novartis Introduction and Business Overview
    Table 84. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Novartis Pediatric Vaccines Product Offerings
    Table 86. Novartis Recent Development
    Table 87. Takeda Pharmaceutical Company Information
    Table 88. Takeda Pharmaceutical Introduction and Business Overview
    Table 89. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Takeda Pharmaceutical Pediatric Vaccines Product Offerings
    Table 91. Takeda Pharmaceutical Recent Development
    Table 92. Bavarian Nordic Company Information
    Table 93. Bavarian Nordic Introduction and Business Overview
    Table 94. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Bavarian Nordic Pediatric Vaccines Product Offerings
    Table 96. Bavarian Nordic Recent Development
    Table 97. Baxter Company Information
    Table 98. Baxter Introduction and Business Overview
    Table 99. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Baxter Pediatric Vaccines Product Offerings
    Table 101. Baxter Recent Development
    Table 102. LG Life Sciences Company Information
    Table 103. LG Life Sciences Introduction and Business Overview
    Table 104. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. LG Life Sciences Pediatric Vaccines Product Offerings
    Table 106. LG Life Sciences Recent Development
    Table 107. Lupin Company Information
    Table 108. Lupin Introduction and Business Overview
    Table 109. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Lupin Pediatric Vaccines Product Offerings
    Table 111. Lupin Recent Development
    Table 112. S K Chemicals Company Information
    Table 113. S K Chemicals Introduction and Business Overview
    Table 114. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. S K Chemicals Pediatric Vaccines Product Offerings
    Table 116. S K Chemicals Recent Development
    Table 117. Mitsubishi Tanabe Pharma Company Information
    Table 118. Mitsubishi Tanabe Pharma Introduction and Business Overview
    Table 119. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offerings
    Table 121. Mitsubishi Tanabe Pharma Recent Development
    Table 122. Janssen Company Information
    Table 123. Janssen Introduction and Business Overview
    Table 124. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Janssen Pediatric Vaccines Product Offerings
    Table 126. Janssen Recent Development
    Table 127. Shenzhen Kangtai Biological Products Company Information
    Table 128. Shenzhen Kangtai Biological Products Introduction and Business Overview
    Table 129. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offerings
    Table 131. Shenzhen Kangtai Biological Products Recent Development
    Table 132. Sinovac Biotech Company Information
    Table 133. Sinovac Biotech Introduction and Business Overview
    Table 134. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Sinovac Biotech Pediatric Vaccines Product Offerings
    Table 136. Sinovac Biotech Recent Development
    Table 137. Bharat Biotech Company Information
    Table 138. Bharat Biotech Introduction and Business Overview
    Table 139. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Bharat Biotech Pediatric Vaccines Product Offerings
    Table 141. Bharat Biotech Recent Development
    Table 142. Crucell Company Information
    Table 143. Crucell Introduction and Business Overview
    Table 144. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. Crucell Pediatric Vaccines Product Offerings
    Table 146. Crucell Recent Development
    Table 147. Dynavax Company Information
    Table 148. Dynavax Introduction and Business Overview
    Table 149. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Dynavax Pediatric Vaccines Product Offerings
    Table 151. Dynavax Recent Development
    Table 152. Serum Institute of India Company Information
    Table 153. Serum Institute of India Introduction and Business Overview
    Table 154. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Serum Institute of India Pediatric Vaccines Product Offerings
    Table 156. Serum Institute of India Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Pediatric Vaccines Downstream Customers
    Table 160. Pediatric Vaccines Distributors List
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pediatric Vaccines Product Picture
    Figure 2. Global Pediatric Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Pediatric Vaccines Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Pediatric Vaccines Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Pediatric Vaccines Report Years Considered
    Figure 7. Global Pediatric Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Pediatric Vaccines Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Revenue in 2023
    Figure 10. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Diphtheria Picture
    Figure 12. Influenza Picture
    Figure 13. Hepatitis Picture
    Figure 14. Pneumococcal Diseases Picture
    Figure 15. Meningococcal Diseases Picture
    Figure 16. Others Picture
    Figure 17. Global Pediatric Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Pediatric Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Pediatric Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Pediatric Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Pediatric Vaccines Price by Type (2019-2030) & (USD/Unit)
    Figure 22. Product Picture of Newborn
    Figure 23. Product Picture of Infant
    Figure 24. Product Picture of Child
    Figure 25. Product Picture of Dolescent
    Figure 26. Global Pediatric Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Pediatric Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Pediatric Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 29. Global Pediatric Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Pediatric Vaccines Price by Application (2019-2030) & (USD/Unit)
    Figure 31. North America Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Pediatric Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Pediatric Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Pediatric Vaccines Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Pediatric Vaccines Sales Volume (%), (2019-2030)
    Figure 43. United States Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Pediatric Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Pediatric Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Pediatric Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 64. Pediatric Vaccines Industrial Chain
    Figure 65. Pediatric Vaccines Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS